151 related articles for article (PubMed ID: 2945065)
21. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
22. Effects of intracerebroventricular atrial natriuretic factor on angiotensin II- or sodium-induced blood pressure elevation and natriuresis.
Yoshida K; Kawano Y; Kawamura M; Kuramochi M; Omae T
J Hypertens; 1989 Aug; 7(8):639-43. PubMed ID: 2530271
[TBL] [Abstract][Full Text] [Related]
23. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
24. Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide.
Di Nicolantonio R; Morgan TO
Clin Exp Hypertens A; 1987; 9(1):19-32. PubMed ID: 2953509
[TBL] [Abstract][Full Text] [Related]
25. Renal and cardiovascular effects of atrial natriuretic peptide in Wistar-Kyoto and spontaneously hypertensive rats during a chronic salt loading.
Gradin K; Persson B
Acta Physiol Scand; 1987 Oct; 131(2):273-81. PubMed ID: 2960130
[TBL] [Abstract][Full Text] [Related]
26. Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats.
Yamada T; Nakao K; Morii N; Itoh H; Shiono S; Sakamoto M; Sugawara A; Saito Y; Ohno H; Kanai A
Eur J Pharmacol; 1986 Jun; 125(3):453-6. PubMed ID: 2942414
[TBL] [Abstract][Full Text] [Related]
27. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
[TBL] [Abstract][Full Text] [Related]
28. Central interaction of the brain atrial natriuretic polypeptide (ANP) system and the brain renin-angiotensin system in ANP secretion from heart--evidence for possible brain-heart axis.
Itoh H; Nakao K; Yamada T; Morii N; Shiono S; Sugawara A; Saito Y; Mukoyama M; Arai H; Imura H
Can J Physiol Pharmacol; 1988 Mar; 66(3):255-61. PubMed ID: 2968140
[TBL] [Abstract][Full Text] [Related]
29. Effects of centrally administered atrial natriuretic polypeptide on sympathetic nerve activity and blood flow to the kidney in conscious rats.
Kannan H; Ueta Y; Nakamura T; Yamashita H; Hayashida Y
Neurosci Lett; 1990 Aug; 116(1-2):123-9. PubMed ID: 2147980
[TBL] [Abstract][Full Text] [Related]
30. The effects of intravenous injection of alpha-human atrial natriuretic polypeptide on blood pressure, renal hemodynamics and urinary kinin excretion in anesthetized rabbits.
Nushiro N; Abe K; Seino M; Omata K; Yoshinaga K
Tohoku J Exp Med; 1987 Feb; 151(2):221-31. PubMed ID: 2953089
[TBL] [Abstract][Full Text] [Related]
31. Renal effect of atrial natriuretic polypeptide: comparison with standard saluretics.
Shimizu T; Nakamura M
Eur J Pharmacol; 1986 Aug; 127(3):249-59. PubMed ID: 2944754
[TBL] [Abstract][Full Text] [Related]
32. Natriuretic and hypotensive effects of brain natriuretic peptide (BNP) in spontaneously hypertensive rats.
Kita T; Kida O; Kato J; Nakamura S; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K
Life Sci; 1989; 44(21):1541-5. PubMed ID: 2525217
[TBL] [Abstract][Full Text] [Related]
33. Centrally administered atrial natriuretic factor inhibits central angiotensin-induced natriuresis.
Rohmeiss P; Demmert G; Rettig R; Unger T
Brain Res; 1989 Nov; 502(1):198-203. PubMed ID: 2531013
[TBL] [Abstract][Full Text] [Related]
34. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
35. Intranasal administration of alpha-human natriuretic peptide produces a prolonged diuresis in healthy man.
Shionoiri H; Kaneko Y
Life Sci; 1986 Mar; 38(9):773-8. PubMed ID: 2936943
[TBL] [Abstract][Full Text] [Related]
36. Antidipsogenic action of alpha-human atrial natriuretic polypeptide administered intracerebroventricularly in rats.
Nakamura M; Katsuura G; Nakao K; Imura H
Neurosci Lett; 1985 Jul; 58(1):1-6. PubMed ID: 2931621
[TBL] [Abstract][Full Text] [Related]
37. Effects of centrally administered angiotensin on sympathetic nerve activity and blood flow to the kidney in conscious rats.
Kannan H; Nakamura T; Jin XJ; Hayashida Y; Yamashita H
J Auton Nerv Syst; 1991 Jun; 34(2-3):201-10. PubMed ID: 1918810
[TBL] [Abstract][Full Text] [Related]
38. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
39. Role of atrial natriuretic peptide in sodium balance in conscious spontaneously hypertensive rats.
Seymour AA; Swerdel JN; Fennell SA; Kratunis VJ; Asaad MM
Am J Physiol; 1990 Apr; 258(4 Pt 2):F916-26. PubMed ID: 2139545
[TBL] [Abstract][Full Text] [Related]
40. An oxidized analog of alpha-human atrial natriuretic polypeptide is a selective agonist for the atrial-natriuretic-polypeptide clearance receptor which lacks a guanylate cyclase.
Koyama S; Terai T; Inoue T; Inomata K; Tamura K; Kobayashi Y; Kyogoku Y; Kobayashi M
Eur J Biochem; 1992 Feb; 203(3):425-32. PubMed ID: 1346519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
